Business Description
Cardio Diagnostics Holdings Inc
NAICS : 541714
SIC : 8731
ISIN : US14159C2026
Total Employee Number:
17Description
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 13.28 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.09 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.68 | |||||
Beneish M-Score | -3.26 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.5 | |||||
3-Year EBITDA Growth Rate | 57.4 | |||||
3-Year EPS without NRI Growth Rate | 56.2 | |||||
3-Year FCF Growth Rate | 58.8 | |||||
3-Year Book Growth Rate | -34.5 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.55 | |||||
9-Day RSI | 32.28 | |||||
14-Day RSI | 35.59 | |||||
3-1 Month Momentum % | 22.35 | |||||
6-1 Month Momentum % | 30 | |||||
12-1 Month Momentum % | -46.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 15.77 | |||||
Quick Ratio | 15.77 | |||||
Cash Ratio | 14.41 | |||||
Days Sales Outstanding | 197.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -79.3 | |||||
Shareholder Yield % | -82.29 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -39052.94 | |||||
Net Margin % | -39123.53 | |||||
EBITDA Margin % | -36882.35 | |||||
FCF Margin % | -37200 | |||||
OCF Margin % | -34635.29 | |||||
ROE % | -73.69 | |||||
ROA % | -68.16 | |||||
ROIC % | -275.11 | |||||
3-Year ROIIC % | -143.83 | |||||
ROC (Joel Greenblatt) % | -415.76 | |||||
ROCE % | -71.55 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 174.46 | |||||
PB Ratio | 0.52 | |||||
Price-to-Tangible-Book | 0.58 | |||||
EV-to-EBIT | 0.29 | |||||
EV-to-EBITDA | 0.3 | |||||
EV-to-Revenue | -111.71 | |||||
EV-to-FCF | 0.3 | |||||
Price-to-GF-Value | 0.57 | |||||
| Price-to-Net-Current-Asset-Value | 0.65 | |||||
| Price-to-Net-Cash | 0.72 | |||||
Earnings Yield (Greenblatt) % | 344.83 | |||||
FCF Yield % | -136.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CDIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cardio Diagnostics Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.017 | ||
| EPS (TTM) ($) | -3.38 | ||
| Beta | 6.9241 | ||
| 3-Year Sharpe Ratio | 0.49 | ||
| 3-Year Sortino Ratio | 2.11 | ||
| Volatility % | 355.91 | ||
| 14-Day RSI | 35.59 | ||
| 14-Day ATR ($) | 0.146596 | ||
| 20-Day SMA ($) | 1.76488 | ||
| 12-1 Month Momentum % | -46.25 | ||
| 52-Week Range ($) | 0.97 - 7.91 | ||
| Shares Outstanding (Mil) | 2.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cardio Diagnostics Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cardio Diagnostics Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-12 | In 105 days | ||
| General meeting for 2026 | 2026-10-15 10:00 | In 78 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 15 days | ||
| First quarter earnings results for 2026 | 2026-05-15 | 1.68 (-10.16%) | ||
| Annual report for 2025 | 2026-03-13 | 4.56 (-2.15%) | ||
| Third quarter earnings results for 2025 | 2025-11-12 | 3.81 (-1.04%) | ||
| General meeting for 2025 | 2025-10-15 10:00 | 4.49 (+4.42%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 3.82 (+0.79%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 4.53 (-10.65%) | ||
| 0.0333333:1 Stock Split | 2025-05-13 | 4.72 (-15.90%) |
Show
Entries
Cardio Diagnostics Holdings Inc Frequently Asked Questions
What is Cardio Diagnostics Holdings Inc(CDIO)'s stock price today?
The current price of CDIO is $1.57. The 52 week high of CDIO is $7.91 and 52 week low is $0.97.
When is next earnings date of Cardio Diagnostics Holdings Inc(CDIO)?
The next earnings date of Cardio Diagnostics Holdings Inc(CDIO) is 2026-08-14 Est..
Does Cardio Diagnostics Holdings Inc(CDIO) pay dividends? If so, how much?
Cardio Diagnostics Holdings Inc(CDIO) does not pay dividend.
Guru Commentaries on NAS:CDIO
No articles.
Press Release
Articles on Cardio Diagnostics Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers